NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Gynecology



Reports advance knowledge in gynecology research



September 8th, 2005

Reports from the People's Republic of China, United Kingdom and United States highlight recent research on gynecology.

Study 1: Antisurvivin oligonucleotides limit the growth of ovarian cancer cells.

"Survivin, an anti-apoptosis gene that is abnormally overexpressed in a variety of human tumors, may play an important role in the carcinogenesis and drug resistance of cancer. This study was designed to explore the effects of liposome-survivin antisense oligonucleotide (Lip-ASODN) on the growth and apoptosis of human ovarian cancer cell lines, A2780 and SKOV3," scientists writing in the journal Oncology Reports state.

"To...


Source: Women's Health Weekly (2005-09-08)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login